Mitchell Sinkler & Starr Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.62M |
| 2 |
Apple
AAPL
|
+$726K |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$535K |
| 4 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$509K |
| 5 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$441K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$347K |
| 2 |
PepsiCo
PEP
|
+$227K |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$192K |
| 4 |
Merck
MRK
|
+$182K |
| 5 |
Eli Lilly
LLY
|
+$163K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.11% |
| 2 | Technology | 12.83% |
| 3 | Consumer Staples | 12.68% |
| 4 | Industrials | 11.48% |
| 5 | Communication Services | 8.44% |
Similar funds
Mitchell Sinkler & Starr's Q4 2019 Portfolio in Review
As of Q4 2019, Mitchell Sinkler & Starr held 103 positions worth $94.1M, up 21% from $78.1M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Mitchell Sinkler & Starr deployed $10.7M of net new capital in Q4 2019, opening 15 new positions and adding to 36 existing holdings. Its largest new stake was iShares 5-10 Year Investment Grade Corporate Bond ETF: 9,250 shares worth $536K.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Charles Schwab, an estimated $347K trimmed.
- Mitchell Sinkler & Starr's largest Q4 2019 buy was iShares 5-10 Year Investment Grade Corporate Bond ETF: 9,250 shares worth $536K.
- Mitchell Sinkler & Starr added most to Procter & Gamble in Q4 2019, an estimated $1.62M increase.
- Mitchell Sinkler & Starr's biggest Q4 2019 reduction was Charles Schwab, cutting an estimated $347K.
- Mitchell Sinkler & Starr's ten largest holdings make up 28% of its $94.1M portfolio in Q4 2019.
- Mitchell Sinkler & Starr opened 15 new positions and closed 0 in Q4 2019.
- Mitchell Sinkler & Starr's portfolio value rose 21% quarter-over-quarter to $94.1M.
Based on Mitchell Sinkler & Starr's 13F filing for Q4 2019, filed 9 Jan 2020.